Savara
SVRA
#5910
Rank
C$1.43 B
Marketcap
C$7.07
Share price
-3.73%
Change (1 day)
73.26%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -C$0.17 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$0.14 Billion a decrease over its 2023 earnings that were of -C$74.94 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$0.17 Billion23.74%
2024 -C$0.14 Billion75.29%
2023 -C$74.94 Million43.38%
2022 -C$52.27 Million-11.31%
2021 -C$58.93 Million-13.3%
2020 -C$67.97 Million-36.53%
2019 -C$0.11 Billion13.76%
2018 -C$94.14 Million105.54%
2017 -C$45.8 Million34.11%
2016 -C$34.16 Million-37.43%
2015 -C$54.58 Million38.81%
2014 -C$39.32 Million33.62%
2013 -C$29.43 Million38.49%
2012 -C$21.25 Million24.59%
2011 -C$17.06 Million-36.5%
2010 -C$26.86 Million-3.14%
2009 -C$27.73 Million-23.28%
2008 -C$36.15 Million8.52%
2007 -C$33.31 Million-34.14%
2006 -C$50.57 Million184.43%
2005 -C$17.78 Million90.75%
2004 -C$9.33 Million190.35%
2003 -C$3.22 Million11.64%
2002 -C$2.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.22 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$24.88 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA